CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) announced 10 scientific abstracts from the company's portfolio of cystic fibrosis medicines. The company said, collectively...
Original Article: Vertex Pharma Presents Data From KALYDECO Studies